Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene

View through CrossRef
Abstract Background Congenital neutropenia is a rare disease. Recurrent infections since young age are the presentation. The most common mutation causing severe congenital neutropenia (SCN) and cyclic neutropenia (CyN) is the ELANE gene. The objectives of this study were to screen the three common genetic mutations of ELANE , HAX1 and GFI1 in children with chronic neutropenia and to describe the clinical characteristics of children who had the mutations. Methods Infants having ANC < 1,000/cu mm or children aged > 1 year having ANC < 1,500/cu mm at least 3 times in 3 months were enrolled in the study. Patients who had acquired neutropenia due to infection, immune deficiency, or drugs were excluded. The ELANE gene was first studied; and if mutations were not identified, the HAX1 and GFI1 genes were further examined. Results A total of 60 patients were enrolled in the study. The median (range) age, ratio of female to male, ANC, and last follow-up age were 9.2 (0.5–45.2) months, 1:1.2, 248 (0–1,101) /cu mm, and 19.9 (3.5–202.3) months, respectively. Infections were noted in 67.3% of all patients. ELANE gene mutation was found in only four patients (6.7%), and the rest (56 patients) showed no mutations in the HAX1 and GFI1 genes. In patients without mutations, 66.0% had normal ANC during the follow-up, with a median (range) age for normal ANC of 19.8 (4.0–60.0) months. Two novel mutations p. Ala79del (c.234_236del) and p. Val197GlufsTer18 (c.589_590insAGGCCGGC) were identified, and they respectively cause SCN and CyN. Patients with the two novel mutations presented with several episodes of infection, including pneumonia, sepsis, abscess, otitis media, and gum infection. Conclusion The genetic screening for ELANE , HAX1 , and GFI1 gene mutations in 60 patients with chronic neutropenia could identify four patients (6.7%) with ELANE gene mutation and two novel mutations, p. Ala79del in exon 3 and p. Val197GlufsTer18 in exon 4 causing SCN; and CyN, respectively.
Title: Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene
Description:
Abstract Background Congenital neutropenia is a rare disease.
Recurrent infections since young age are the presentation.
The most common mutation causing severe congenital neutropenia (SCN) and cyclic neutropenia (CyN) is the ELANE gene.
The objectives of this study were to screen the three common genetic mutations of ELANE , HAX1 and GFI1 in children with chronic neutropenia and to describe the clinical characteristics of children who had the mutations.
Methods Infants having ANC < 1,000/cu mm or children aged > 1 year having ANC < 1,500/cu mm at least 3 times in 3 months were enrolled in the study.
Patients who had acquired neutropenia due to infection, immune deficiency, or drugs were excluded.
The ELANE gene was first studied; and if mutations were not identified, the HAX1 and GFI1 genes were further examined.
Results A total of 60 patients were enrolled in the study.
The median (range) age, ratio of female to male, ANC, and last follow-up age were 9.
2 (0.
5–45.
2) months, 1:1.
2, 248 (0–1,101) /cu mm, and 19.
9 (3.
5–202.
3) months, respectively.
Infections were noted in 67.
3% of all patients.
ELANE gene mutation was found in only four patients (6.
7%), and the rest (56 patients) showed no mutations in the HAX1 and GFI1 genes.
In patients without mutations, 66.
0% had normal ANC during the follow-up, with a median (range) age for normal ANC of 19.
8 (4.
0–60.
0) months.
Two novel mutations p.
Ala79del (c.
234_236del) and p.
Val197GlufsTer18 (c.
589_590insAGGCCGGC) were identified, and they respectively cause SCN and CyN.
Patients with the two novel mutations presented with several episodes of infection, including pneumonia, sepsis, abscess, otitis media, and gum infection.
Conclusion The genetic screening for ELANE , HAX1 , and GFI1 gene mutations in 60 patients with chronic neutropenia could identify four patients (6.
7%) with ELANE gene mutation and two novel mutations, p.
Ala79del in exon 3 and p.
Val197GlufsTer18 in exon 4 causing SCN; and CyN, respectively.

Related Results

Gfi1 Protein Levels Are Upregulated upon Myeloid Differentiation Due to Diminished Proteasomal Degradation.
Gfi1 Protein Levels Are Upregulated upon Myeloid Differentiation Due to Diminished Proteasomal Degradation.
Abstract Granulocytes and monocytes play an essential role in the innate immune system and the inflammatory system. The generation of these differentiated myeloid ce...
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
The Transcription Factor Gfi1 Negatively Regulates NLRP3 inflammasome-Mediated IL-1β Secretion in Macrophages
Abstract Background: IL-1β secretion is tightly controlled at the transcriptional and post-translational levels. The NLRP3 inflammasome, a multiprotein complex compo...
Gfi1 Protein Turnover Is Regulated by the Ubiquitin Ligase Triad1.
Gfi1 Protein Turnover Is Regulated by the Ubiquitin Ligase Triad1.
Abstract The transcriptional repressor Growth factor independence-1 (Gfi1) plays an essential role during various stages of hematopoiesis. It is crucial for the self...
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes
Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes
Abstract Gfi1 is a transcriptional repressor essential during myeloid differentiation. Gfi1−/− mice exhibit a block in myeloid differentiation resulting in the accum...
Hax1 regulates neutrophil adhesion and motility through RhoA
Hax1 regulates neutrophil adhesion and motility through RhoA
Kostmann disease is an inherited severe congenital neutropenia syndrome associated with loss-of-function mutations in an adaptor protein HS1-associated protein X-1 (Hax1). How Hax1...

Back to Top